Letter to the Editor

Affiliations

¹ Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. Electronic address: lara.bellardita@istitutotumori.mi.it.
² Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Department of Oncology and Onco-hemato, Università degli Studi di Milano, Italy; Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.

Comment

Lara Bellardita et al. Contemp Clin Trials. 2019 Sep.

. 2019 Sep:84:105825.

doi: 10.1016/j.cct.2019.105825. Epub 2019 Aug 13.

¹ Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. Electronic address: lara.bellardita@istitutotumori.mi.it.
² Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Department of Oncology and Onco-hemato, Università degli Studi di Milano, Italy; Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.

No abstract available

Comment on

Randomized trial evaluating the role of weight loss in overweight and obese men with early stage prostate Cancer on active surveillance: Rationale and design of the Prostate Cancer Active Lifestyle Study (PALS).
Schenk JM, Neuhouser ML, Beatty SJ, VanDoren M, Lin DW, Porter M, Gore JL, Gulati R, Plymate SR, Wright JL. Schenk JM, et al. Contemp Clin Trials. 2019 Jun;81:34-39. doi: 10.1016/j.cct.2019.04.004. Epub 2019 Apr 16. Contemp Clin Trials. 2019. PMID: 31002955 Free PMC article.